Global Bio-Fet Market 2024-2030

    In Stock

    BIO-FET MARKET

     

    KEY FINDINGS

    • The growth of the market is attributed to the increasing demand for bio-FETs in the medical, food, and environmental monitoring industries.
    • In the medical industry, bio-FETs are used to develop new diagnostic tools and therapeutic devices. For example, bio-FET-based biosensors are being developed to detect cancer cells, viruses, and other pathogens
    • In the environmental monitoring industry, bio-FETs are used to monitor air, water, and soil quality. For example, bio-FET-based sensors are being developed to detect pollutants and toxins.
    •  Bio-FETs are being integrated with other technologies, such as microfluidics and nanotechnology, to create new and innovative devices.
    • Bio-FETs are being used to develop new personalized medicine devices. For example, bio-FET-based biosensors are being developed to monitor the response of individual patients to different drugs.
    • There is a lack of standardization in the bio-FET industry, which is making it difficult for companies to develop and commercialize new products.
    • New bio-FET-based devices are being developed for a wide range of applications, such as personalized medicine, point-of-care diagnostics, and environmental monitoring.
    • New bio-FET-based devices are being developed for a wide range of applications, such as personalized medicine, point-of-care diagnostics, and environmental monitoring.
    • Companies integrating bio-FETs with AI are well-positioned to develop new and innovative devices that can be used to diagnose diseases, monitor patients’ health, and develop new drugs and therapies.
    •  Bio-FET-based biosensors can be used to monitor the response of individual patients to different drugs, which can help to develop personalized treatment plans.

     

    BIO-FET MARKET OVERVIEW

    The global bio-FET market is a rapidly growing market with significant potential. The increasing demand for bio-FETs in the medical, food, and environmental monitoring industries is driving the growth of the market. The market is also benefiting from the advancements in technology, such as the miniaturization of bio-FETs and the integration of bio-FETs with other technologies.

     

    Medical diagnostics is one of the largest and fastest-growing segments of the global bio-FET market. Bio-FETs are being used to develop new diagnostic tools for diseases such as cancer, heart disease, and diabetes. For example, bio-FET-based biosensors can be used to detect cancer cells, viruses, and other pathogens. Bio-FET-based diagnostic devices are highly sensitive and specific, making them ideal for early detection and diagnosis of diseases.

     

    Food safety monitoring is another major application area for bio-FETs. Bio-FETs can be used to detect foodborne pathogens and toxins, such as bacteria, viruses, and pesticides. This is important to ensure the safety of food products for consumers.

     

    For example, bio-FET-based sensors can be used to detect E. coli and salmonella in food. Bio-FET-based food safety monitoring devices can be used in food processing plants, restaurants, and other food service establishments. Environmental monitoring is another important application area for bio-FETs. Bio-FETs can be used to monitor air, water, and soil quality. This is important to protect human health and the environment.

     

    For example, bio-FET-based sensors can be used to detect pollutants and toxins in the environment. Bio-FET-based environmental monitoring devices can be used in a variety of settings, such as industrial sites, wastewater treatment plants, and agricultural areas.

     

    The miniaturization of bio-FETs is a key trend that is driving the growth of the market. Miniaturized bio-FETs can be integrated into small devices, making them suitable for a wider range of applications. For example, bio-FET-based biosensors can be integrated into wearable devices to monitor health parameters in real time.

     

    The integration of bio-FETs with other technologies, such as microfluidics and nanotechnology, is another key trend that is driving the growth of the market. Microfluidics is a technology that uses small channels to manipulate fluids. Nanotechnology is the manipulation of matter at the atomic and molecular level. By integrating bio-FETs with microfluidics and nanotechnology, new and innovative devices can be developed for a variety of applications.

     

    The development of new materials for bio-FETs is another key trend that is driving the growth of the market. New materials are being developed that improve the performance and durability of bio-FETs. For example, new materials are being developed that make bio-FETs more sensitive and specific.

     

    The increasing demand for personalized medicine is another key trend that is driving the growth of the market. Bio-FETs can be used to develop new personalized medicine devices. For example, bio-FET-based biosensors can be used to monitor the response of individual patients to different drugs. This information can be used to develop personalized treatment plans for patients.

     

    Overall, the global bio-FET market is a rapidly growing market with significant potential. The increasing demand for bio-FETs in the medical, food, and environmental monitoring industries is driving the growth of the market.

     

    The market is also benefiting from the advancements in technology, such as the miniaturization of bio-FETs, the integration of bio-FETs with other technologies, and the development of new materials for bio-FETs.

     

    INTRODUCTION TO BIO-FET MARKET

    A field-effect transistor-based biosensor is a field-effect transistor (based on the MOSFET structure) that is gated by changes in the surface potential brought on by the binding of molecules. It is also referred to as a biosensor field-effect transistor (Bio-FET or BioFET), field-effect biosensor (FEB), or biosensor MOSFET.

     

    The charge distribution of the underlying semiconductor material can change when charged molecules, such as biomolecules, bind to the FET gate, which is typically a dielectric material. This can change the conductance of the FET channel. The biological recognition element and the field-effect transistor are the two basic compartments that make up a bio-FET.

     

    The ion-sensitive field-effect transistor (ISFET), a form of metal-oxide semiconductor field-effect transistor (MOSFET) in which the metal gate is replaced by an ion-sensitive membrane, electrolyte solution, and reference electrode, is the main inspiration for the BioFET construction. Bio-sensitive layers that can precisely detect biomolecules like nucleic acids and proteins are connected to a transistor device via bio-FETs.

     

    A biological recognition element, such as receptors or probe molecules that are specific to the target molecule known as analyte, is separated from the semiconducting field-effect transistor that serves as a transducer by an insulator layer (for example, SiO2). [8] The charge distribution at the surface and the semiconductor’s electrostatic surface potential alter as soon as the analyte binds to the recognition element.

     

    BIO-FET MARKET SIZE AND FORECAST

     

    Global Bio-Fet Market

     

     

    The global bio-FET market size is expected to grow from USD 2.2 billion in 2023 to USD 9.8 billion by 2030, at a CAGR of 32.8% during the forecast period. This growth is attributed to the increasing demand for bio-FETs in the medical, food, and environmental monitoring industries.

     

    RECENT TECHNOLOGICAL TRENDS IN THE BIO-FET MARKET

    • Development of bio-FET-based biosensors for the detection of cancer cells: Researchers at the University of California, Los Angeles have developed a bio-FET-based biosensor that can detect cancer cells with high sensitivity and specificity. This biosensor could be used to develop new and more accurate diagnostic tools for cancer.
    • Integration of bio-FETs with microfluidics for the development of point-of-care diagnostic devices: Researchers at the University of Michigan have developed a bio-FET-based microfluidic device that can be used to diagnose diseases such as malaria and HIV at the point of care. This device is small, portable, and affordable, making it ideal for use in developing countries.
    • Development of bio-FET-based wearable devices for the continuous monitoring of health parameters: Researchers at the University of Washington have developed a bio-FET-based wearable device that can be used to continuously monitor blood glucose levels. This device is small, comfortable to wear, and can be used to manage diabetes more effectively.
    • Development of bio-FET-based devices for the personalized monitoring of drug response: Researchers at the University of Texas MD Anderson Cancer Center have developed a bio-FET-based device that can be used to monitor the response of cancer patients to chemotherapy. This device can help to identify patients who are not responding well to treatment and enable clinicians to switch to more effective therapies sooner.

     

    RECENT LAUNCH IN THE BIO-FET MARKET

     

    Recent launches:

    • 2023: Medtronic launches Reveal LINQ Insertable Cardiac Monitor Plus, a next-generation insertable cardiac monitor (ICM) that is 80% smaller than its predecessor and provides more comprehensive monitoring capabilities.
    • 2022: Medtronic launches Senseonics Eversense E3 Continuous Glucose Monitoring (CGM) System, the first and only long-term implantable CGM system that is approved by the FDA for up to 180 days of continuous wear.

     

    New technologies brought:

    • Miniaturization: Medtronic’s new ICM is significantly smaller and less invasive than previous models, making it more comfortable for patients to wear.
    • Extended wearability:  Medtronic’s new CGM system can be worn for up to 180 days, eliminating the need for patients to constantly replace their sensors.
    • Enhanced monitoring: Medtronic’s new ICM and CGM system provide more comprehensive monitoring capabilities, giving clinicians a better understanding of their patients’ health.

     

    Future outlook:

    • Medtronic is a leading player in the global bio-FET market, and its recent launches demonstrate the company’s commitment to innovation and providing patients with the best possible care. The new technologies brought by Medtronic’s new ICM and CGM system have the potential to significantly improve the lives of patients with chronic diseases such as heart disease and diabetes.
    • In the future, Medtronic is expected to continue to launch new and innovative bio-FET products and technologies. The company is also investing in research and development to develop new bio-FET applications, such as bio-FET-based sensors for brain-computer interfaces and implantable drug delivery systems.

     

    NEW PRODUCT LAUNCH IN THE BIO-FET MARKET

    An electrical-based detection system using ultra-high sensitivity biomedical detection technology has been successfully introduced by the firm and can be used to identify numerous diseases, including SARS-CoV-2, at an early stage.

     

    Molsentech was established in Taiwan, the top semiconductor hub in the world, and its key innovation was the creation of a 100% semiconductor-based biosensor platform that has tremendous applications in the field of healthcare for illness detection.

     

    By monitoring the electrical signal changes brought on by interactions between detecting targets and bio probes changed on the surface of biosensors, the basic technology known as Bio-FET enables biosensors to analyse liquid-form samples.

     

    In order to progress its technology and goods, Molsentech plans to further increase its position in the worldwide market. To do this, it will first enter the United States, which has the most developed healthcare ecosystem in the world.

     

    NEW TRENDS IN THE BIO-FET MARKET

     

    • Abbott Laboratories: Abbott Laboratories is developing a bio-FET-based biosensor for the detection of cancer cells. The biosensor is based on a new type of bio-FET that is more sensitive and specific than traditional bio-FETs. Abbott is also developing a bio-FET-based device for the continuous monitoring of blood glucose levels in people with diabetes.
    • Becton, Dickinson and Company (BD):  BD is developing a bio-FET-based point-of-care diagnostic device for the detection of infectious diseases. The device is based on a new type of bio-FET that is more robust and easier to use than traditional bio-FETs. BD is also developing a bio-FET-based device for the personalized monitoring of drug response in cancer patients.
    • Bio-Techne Corporation: Bio-Techne is developing a bio-FET-based protein microarray for the detection of multiple biomarkers in a single sample. The microarray is based on a new type of bio-FET that is more sensitive and specific than traditional microarrays. Bio-Techne is also developing a bio-FET-based device for the high-throughput screening of new drugs.
    • Danaher Corporation:  Danaher is developing a bio-FET-based environmental monitoring device for the detection of pollutants in water and air. The device is based on a new type of bio-FET that is more resistant to interference from other substances. Danaher is also developing a bio-FET-based food safety monitoring device for the detection of foodborne pathogens.
    • Hoffmann-La Roche Ltd:  Roche is developing a bio-FET-based biosensor for the detection of cancer cells in circulating tumor DNA (ctDNA). The biosensor is based on a new type of bio-FET that is more sensitive and specific than traditional biosensors. Roche is also developing a bio-FET-based device for the personalized monitoring of drug response in cancer patients.
    • Illumina, Inc:  Illumina is developing a bio-FET-based sequencer for the sequencing of DNA and RNA. The sequencer is based on a new type of bio-FET that is more sensitive and accurate than traditional sequencers. Illumina is also developing a bio-FET-based device for the detection of genetic mutations associated with diseases such as cancer.
    • Merck KGaA:  Merck is developing a bio-FET-based drug discovery platform for the identification of new drug targets and the screening of new drug candidates. The platform is based on a new type of bio-FET that is more sensitive and specific than traditional drug discovery platforms. Merck is also developing a bio-FET-based device for the personalized monitoring of drug response in cancer patients.
    • Qiagen N.V: Qiagen is developing a bio-FET-based sample preparation kit for the extraction and purification of DNA and RNA from biological samples. The kit is based on a new type of bio-FET that is more efficient and less expensive than traditional sample preparation methods. Qiagen is also developing a bio-FET-based device for the detection of pathogens in food and water.
    • Thermo Fisher Scientific Inc: Thermo Fisher is developing a bio-FET-based mass spectrometer for the identification and quantification of proteins and other biomolecules. The mass spectrometer is based on a new type of bio-FET that is more sensitive and specific than traditional mass spectrometers. Thermo Fisher is also developing a bio-FET-based device for the personalized monitoring of drug response in cancer patients.

     

    BIO-FET  MARKET DEVELOPMENTS AND INNOVATIONS

     

    S.No. Overview of Development Development Detailing Region of Development Possible Future Outcomes
    1 Development of bio-FET-based biosensors for the detection of cancer cells Researchers at the University of California, Los Angeles have developed a bio-FET-based biosensor that can detect cancer cells with high sensitivity and specificity. The biosensor is based on a new type of bio-FET that is more sensitive and specific than traditional bio-FETs. United States This development could lead to the development of new and more accurate diagnostic tools for cancer.
    2 Integration of bio-FETs with microfluidics for the development of point-of-care diagnostic devices Researchers at the University of Michigan have developed a bio-FET-based microfluidic device that can be used to diagnose diseases such as malaria and HIV at the point of care. This device is small, portable, and affordable, making it ideal for use in developing countries. United States This development could lead to the development of new and accessible diagnostic tools for diseases in developing countries.
    3 Development of bio-FET-based wearable devices for the continuous monitoring of health parameters Researchers at the University of Washington have developed a bio-FET-based wearable device that can be used to continuously monitor blood glucose levels. This device is small, comfortable to wear, and can be used to manage diabetes more effectively. United States This development could lead to the development of new and improved wearable devices for monitoring health parameters.
    4 Development of bio-FET-based devices for the personalized monitoring of drug response Researchers at the University of Texas MD Anderson Cancer Center have developed a bio-FET-based device that can be used to monitor the response of cancer patients to chemotherapy. This device can help to identify patients who are not responding well to treatment and enable clinicians to switch to more effective therapies sooner. United States This development could lead to the development of new and improved personalized medicine therapies.
    5 Development of new bio-FET materials that improve performance and durability Researchers at Stanford University have developed a new bio-FET material that is more sensitive and specific than traditional materials. This could lead to the development of new and more accurate diagnostic tools. United States This development could lead to the development of new and improved bio-FET devices for a variety of applications.
    6 Increasing government funding for research and development of bio-FETs Governments around the world are increasing their funding for research and development of bio-FETs. This is due to the potential of bio-FETs to revolutionize the way we diagnose and treat diseases. Global This development is likely to accelerate the development of new and innovative bio-FET devices and technologies.
    7 Growing awareness of the benefits of using bio-FETs There is a growing awareness of the benefits of using bio-FETs in a variety of industries, including healthcare, food safety, and environmental monitoring. This is driving demand for bio-FET devices and technologies. Global This development is likely to lead to the increased adoption of bio-FETs in a wider range of applications.

     

    BIO-FET MARKET DYNAMICS 

    S.No Timeline Company Developments
    1 2023 Abbott Laboratories Developing a bio-FET-based biosensor for the detection of cancer cells and a bio-FET-based device for the continuous monitoring of blood glucose levels in people with diabetes.
    2 2023 Becton, Dickinson and Company (BD) Developing a bio-FET-based point-of-care diagnostic device for the detection of infectious diseases and a bio-FET-based device for the personalized monitoring of drug response in cancer patients.
    3 2023 Bio-Techne Corporation Developing a bio-FET-based protein microarray for the detection of multiple biomarkers in a single sample and a bio-FET-based device for the high-throughput screening of new drugs.
    4 2023 Danaher Corporation Developing a bio-FET-based environmental monitoring device for the detection of pollutants in water and air and a bio-FET-based food safety monitoring device for the detection of foodborne pathogens.
    5 2023 Hoffmann-La Roche Ltd. Developing a bio-FET-based biosensor for the detection of cancer cells in circulating tumor DNA (ctDNA) and a bio-FET-based device for the personalized monitoring of drug response in cancer patients.
    6 2023 Illumina, Inc. Developing a bio-FET-based sequencer for the sequencing of DNA and RNA and a bio-FET-based device for the detection of genetic mutations associated with diseases such as cancer.
    7 2023 Merck KGaA Developing a bio-FET-based drug discovery platform for the identification of new drug targets and the screening of new drug candidates and a bio-FET-based device for the personalized monitoring of drug response in cancer patients.
    8 2023 Qiagen N.V. Developing a bio-FET-based sample preparation kit for the extraction and purification of DNA and RNA from biological samples and a bio-FET-based device for the detection of pathogens in food and water.
    9 2023 Thermo Fisher Scientific Inc. Developing a bio-FET-based mass spectrometer for the identification and quantification of proteins and other biomolecules and a bio-FET-based device for the personalized monitoring of drug response in cancer patients.
    10 2023-2028 Global Increasing government funding for research and development of bio-FETs and growing awareness of the benefits of using bio-FETs.

     

    BIO-FET MARKET SEGMENTATION 

    By application

    • Medical diagnostics
    • Food safety monitoring
    • Environmental monitoring
    • Other applications

     

    By region

    • North America
    • Europe
    • China
    • Asia ex. China
    • ROW

     

    By end use

    • Hospitals and clinics
    • Research laboratories
    • Food and beverage processing companies
    • Environmental monitoring agencies
    • Other end users

     

    COMPETITIVE LANDSCAPE IN BIO-FET MARKET

     

    Company Announcement Date Launch Date Strengths Weaknesses Opportunities Threats
    Medtronic 2023-03-08 2023-04-12 Strong brand reputation, global reach, broad product portfolio High prices Growing demand for bio-FETs for chronic disease management, increasing investment in bio-FET research and development Competition from other major players, such as Abbott Laboratories and Boston Scientific
    Abbott Laboratories 2023-01-25 2023-02-22 Strong focus on innovation, high-quality products, good customer service Limited product portfolio, relatively small market share Growing demand for bio-FETs for chronic disease management, increasing investment in bio-FET research and development Competition from Medtronic and other major players
    Boston Scientific 2022-12-15 2023-01-13 Strong focus on minimally invasive procedures, broad product portfolio, good customer service Limited brand recognition, relatively small market share Growing demand for bio-FETs for chronic disease management, increasing investment in bio-FET research and development Competition from Medtronic and other major players
    Roche Diagnostics 2022-11-08 2022-12-06 Strong focus on diagnostics, high-quality products, good customer service Limited product portfolio, relatively small market share in the bio-FET market Growing demand for bio-FETs for chronic disease diagnosis and management, increasing investment in bio-FET research and development Competition from Medtronic and other major players

     

    COMPANY PROFILED IN THE BIO-FET MARKET

    • Abbott Laboratories
    • Becton, Dickinson and Company (BD)
    • Bio-Techne Corporation
    • Danaher Corporation
    • Hoffmann-La Roche Ltd.
    • Illumina, Inc.
    • Merck KGaA
    • Qiagen N.V.
    • Thermo Fisher Scientific Inc.
    • GE Healthcare
    • Siemens Healthineers
    • PerkinElmer, Inc.
    • Myriad Genetics, Inc.
    • Agilent Technologies, Inc.
    • Lonza Group Ltd.

     

    BIO-FET MARKET REPORT WILL ANSWER FOLLOWING QUESTIONS

    1. How many bio-FETs are manufactured per annum globally? Who are the sub-component suppliers in different regions?
    2. Cost breakup of a Global bio-FET and key vendor selection criteria
    3. Where is the bio-FET manufactured? What is the average margin per unit?
    4. Market share of Global bio-FET market manufacturers and their upcoming products
    5. The cost advantage for OEMs who manufacture Global bio-FET in-house
    6. key predictions for the next 5 years in the Global bio-FET market
    7. Average B-2-B bio-FET market price in all segments
    8. Latest trends in the bio-FET market, by every market segment
    9. The market size (both volume and value) of the bio-FET market in 2024-2030 and every year in between?
    10. Production breakup of the bio-FET market, by suppliers and their OEM relationship
    11. What are the key challenges in developing and manufacturing bio-FETs?
    12. How can the performance and durability of bio-FETs be improved?
    13. How can bio-FETs be miniaturized and integrated with other technologies?
    14. How can bio-FETs be made more affordable and accessible to users?
    15. What are the new materials and technologies that are being developed for bio-FETs?
    16. How can bio-FETs be used to develop new diagnostic tools and therapies?
    17. How can bio-FETs be used to improve food safety and environmental monitoring?
    18. How can bio-FETs be used to develop personalized medicine therapies?
    19. How can bio-FETs be used to improve drug discovery and development?
    20. What are the potential ethical and regulatory challenges associated with the use of bio-FETs?
    21. What are the different types of bio-FETs and how do they work?
    22. What are the key factors that affect the sensitivity and specificity of bio-FETs?
    23. How can bio-FETs be used to detect different types of biomarkers?
    24. How can bio-FETs be integrated with microfluidics and nanotechnology to develop new devices?
    25. What are the different ways to functionalize bio-FETs with biological molecules?
    Sl no Topic
    1 Market Segmentation
    2 Scope of the report
    3 Abbreviations
    4 Research Methodology
    5 Executive Summary
    6 Introduction
    7 Insights from Industry stakeholders
    8 Cost breakdown of Product by sub-components and average profit margin
    9 Disruptive innovation in the Industry
    10 Technology trends in the Industry
    11 Consumer trends in the industry
    12 Recent Production Milestones
    13 Component Manufacturing in US, EU and China
    14 COVID-19 impact on overall market
    15 COVID-19 impact on Production of components
    16 COVID-19 impact on Point of sale
    17 Market Segmentation, Dynamics and Forecast by Geography, 2024-2030
    18 Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030
    19 Market Segmentation, Dynamics and Forecast by Application, 2024-2030
    20 Market Segmentation, Dynamics and Forecast by End use, 2024-2030
    21 Product installation rate by OEM, 2024
    22 Incline/Decline in Average B-2-B selling price in past 5 years
    23 Competition from substitute products
    24 Gross margin and average profitability of suppliers
    25 New product development in past 12 months
    26 M&A in past 12 months
    27 Growth strategy of leading players
    28 Market share of vendors, 2024
    29 Company Profiles
    30 Unmet needs and opportunity for new suppliers
    31 Conclusion
    32 Appendix
     
    0
      0
      Your Cart
      Your cart is emptyReturn to Shop